NeuroVasx
Maple Grove, Minnesota, United States
About NeuroVasx
NeuroVasx is a medical device company engaged in the development and commercialization of technologies for the minimally-invasive treatment of hemorrhagic and ischemic strokes in the United States and internationally. The company offers cPAX, a polymer strand delivered through a micro catheter for the minimally-invasive treatment of hemorrhagic and ischemic strokes as well as for the embolization of cerebral and intracranial aneurysms, abnormal bulges, and sacs in the wall of an artery in the brain. Its products are used to treat acute stroke and other cerebrovascular disorders. NeuroVasx was founded in 1997 and is based in Maple Grove, Minnesota, United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $8.5M
- Last round: Series Unknown (Oct 2018)
- Website: neurovasxinc.com
- Phone: +1 763-315-0013
Industries & Categories
Health Care, Manufacturing, Medical
Canonical: https://fsome.com/organization/neurovasx-2499653 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.